A Kratomic Bomb: Cardiotoxicities From Mitragyna speciosa Extract

Affiliations

¹ Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.
² Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: Mlloyd2@emory.edu.

Editorial

Vardhmaan Jain et al. JACC Case Rep. 2025.

. 2025 Mar 5;30(5):103110.

doi: 10.1016/j.jaccas.2024.103110.

¹ Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.
² Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: Mlloyd2@emory.edu.

No abstract available

Keywords: Brugada; QRS prolongation; QT prolongation; kratom; mitragynine.

Conflict of interest statement

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

1. Leong Bin Abdullah M.F.I., Singh D. The adverse cardiovascular effects and cardiotoxicity of kratom (Mitragyna speciosa Korth.): a comprehensive review. Front Pharmacol. 2021;12 - PMC - PubMed
1. Miller A.H.F., Krotulski A.J., Walton S.E., et al. Kratom cardiotoxicity: reversible Brugada pattern and QTc prolongation. JACC Case Rep. 2025;30(5) - PubMed
1. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391–1396. - PubMed
1. Yap Y.G., Behr E.R., Camm A.J. Drug-induced Brugada syndrome. Europace. 2009;11:989–994. - PubMed
1. Mizusawa Y., Wilde A.A.M. Brugada syndrome. Circ Arrhythm Electrophysiol. 2012;5:606–616. - PubMed